JP2024542145A5 - - Google Patents
Info
- Publication number
- JP2024542145A5 JP2024542145A5 JP2024526929A JP2024526929A JP2024542145A5 JP 2024542145 A5 JP2024542145 A5 JP 2024542145A5 JP 2024526929 A JP2024526929 A JP 2024526929A JP 2024526929 A JP2024526929 A JP 2024526929A JP 2024542145 A5 JP2024542145 A5 JP 2024542145A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- amino
- imidazole
- benzo
- benzimidazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163276479P | 2021-11-05 | 2021-11-05 | |
| US63/276,479 | 2021-11-05 | ||
| US202263356861P | 2022-06-29 | 2022-06-29 | |
| US63/356,861 | 2022-06-29 | ||
| PCT/US2022/048973 WO2023081367A2 (en) | 2021-11-05 | 2022-11-04 | 2-amino imidazole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024542145A JP2024542145A (ja) | 2024-11-13 |
| JP2024542145A5 true JP2024542145A5 (cg-RX-API-DMAC7.html) | 2026-03-09 |
Family
ID=84488422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526929A Pending JP2024542145A (ja) | 2021-11-05 | 2022-11-04 | Prmt5阻害剤としての2-アミノイミダゾール誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20260109709A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4426690A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024542145A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240157631A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023081367A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024038004A1 (en) | 2022-08-15 | 2024-02-22 | Astrazeneca Ab | Mta-cooperative prmt5 inhibitors for use in the treatment of cancer |
| WO2024170488A1 (en) | 2023-02-13 | 2024-08-22 | Astrazeneca Ab | Prmt5 inhibitor for use in cancer therapy |
| PE20260121A1 (es) | 2023-04-21 | 2026-01-16 | Gilead Sciences Inc | Inhibidores de prmt5 y usos de los mismos |
| WO2025217007A1 (en) | 2024-04-08 | 2025-10-16 | Mirati Therapeutics, Inc. | Combination therapies using prmt5 inhibitors and immune checkpoint inhibitors for the treatment of cancer |
| US20250312343A1 (en) | 2024-04-08 | 2025-10-09 | Mirati Therapeutics, Inc. | Combination therapies using prmt5 inhibitors and kras g12d inhibitors for the treatment of cancer |
| US20250312351A1 (en) | 2024-04-08 | 2025-10-09 | Mirati Therapeutics, Inc. | Combination therapies using prmt5 inhibitors and sos1 inhibitors for the treatment of cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120208880A (zh) * | 2019-09-12 | 2025-06-27 | 米拉蒂医疗股份有限公司 | Mta-协同prmt5抑制剂 |
-
2022
- 2022-11-04 KR KR1020247018658A patent/KR20240157631A/ko active Pending
- 2022-11-04 EP EP22822743.5A patent/EP4426690A2/en active Pending
- 2022-11-04 US US18/707,295 patent/US20260109709A1/en active Pending
- 2022-11-04 WO PCT/US2022/048973 patent/WO2023081367A2/en not_active Ceased
- 2022-11-04 JP JP2024526929A patent/JP2024542145A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7389856B2 (ja) | Usp30阻害剤としての1-シアノ-ピロリジン化合物 | |
| AU2020345899B2 (en) | MTA-cooperative PRMT5 inhibitors | |
| AU2017376624B2 (en) | Aminothiazole compounds as c-Kit inhibitors | |
| CN107001339B (zh) | 新化合物 | |
| AU2006330587B2 (en) | Azaindole inhibitors of aurora kinases | |
| KR100908155B1 (ko) | 히스타민 h3 수용체 리간드로서 유용한테트라하이드로나프티리딘 유도체 | |
| JP2020514267A5 (cg-RX-API-DMAC7.html) | ||
| CN119173515A (zh) | 泛素特异性蛋白酶1 (usp1)的小分子抑制剂和其用途 | |
| US20100022502A1 (en) | Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases | |
| AU6143899A (en) | Fused pyridine inhibitors of cgmp phosphodiesterase | |
| WO2014110086A2 (en) | 3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof | |
| CN104428293A (zh) | 调节TNFα的苯并咪唑类 | |
| CN104271133A (zh) | 1H-吡唑并[3,4-b]吡啶及其治疗应用 | |
| AU2022307534B2 (en) | Pyridinone mk2 inhibitors and uses thereof | |
| CA2889572A1 (en) | Heteroaromatic compounds as dopamine d1 ligands | |
| JP2024542145A (ja) | Prmt5阻害剤としての2-アミノイミダゾール誘導体 | |
| US12371432B2 (en) | Haloallylamine compounds and application thereof | |
| CA3171950A1 (en) | Collagen 1 translation inhibitors and methods of use thereof | |
| KR102005121B1 (ko) | 2-아미노-3-(이미다졸-2-일)-피리딘-4-온 유도체 및 vegf 수용체 키나제 억제제로서의 그의 용도 | |
| US20230116201A1 (en) | Collagen 1 translation inhibitors and methods of use thereof | |
| JP2017226661A (ja) | 脆弱x症候群、パーキンソン病又は逆流性疾患の治療に有用なジアゼピノン誘導体 | |
| CN118974035A (zh) | 作为prmt5抑制剂的2-氨基咪唑衍生物 | |
| HK1240929B (en) | Novel compounds |